Skip to main content

Table 3 Univariate and multivariate analysis of possible factors associated with low eGFR at week 24 after switching NRTI

From: Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

Parameters Univariate analysis Multivariate analysis
  Beta 95%CI of Beta P value Beta 95%CI of Beta P value
eGFR at week 0 0.572 0.342 to 0.743 <0.001 0.529 0.296 to 0.707 <0.001
Receiving efavirenz 0.331 3.734 to 24.596 0.009 0.245 1.438 to 19.521 0.024
Age -0.228 -1.325 to 0.063 0.074 -0.016 -0.649 to 0.562 0.886